RT Journal Article
SR Electronic
T1 Developing a User-Friendly Oropharyngeal HPV-16 Point-of-Care Diagnostic: HPV-16 Virus Detection in Oral Rinse Sample Matrix With Colorimetric Loop-Mediated Isothermal Amplification
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.15.24307441
DO 10.1101/2024.05.15.24307441
A1 Halphen, John
A1 Wright, Nicholas A.
A1 Fisher, Samantha
A1 Juarez, San Juana I.
A1 Sanchez, Lisa
A1 Riedel, Timothy E.
YR 2024
UL http://medrxiv.org/content/early/2024/05/16/2024.05.15.24307441.abstract
AB Human papillomavirus type 16 (HPV-16) is a highly carcinogenic variant that is responsible for the majority of human oropharyngeal cancers. HPV-16 is critically under-tested, and there are currently no commercially available HPV-16 diagnostics for oral infection sites. We developed an oral HPV-16 diagnostic system with the goal of being as user-friendly and non-invasive as possible. The system tests an oral rinse sample from the patient, is interpreted via a color change from pink to yellow, and can be incubated in a battery-powered coffee mug. The colorimetric loop-mediated isothermal amplification-based diagnostic is sensitive to synthetic HPV-16 E7/E1 DNA at levels as low as 103 copies after 20 minutes of incubation. This study supports the potential to develop an easy-to-assemble and easy-to-use diagnostic for oropharyngeal HPV-16 infections.Competing Interest StatementThe research lab where this work is completed is part of the UT FRI Program which is an educational program for undergraduate science students. This lab receives donations of the NEB Colorimetric 2X Master Mix through an educational partnership with NEB.Funding StatementThis study was funded by the College of Natural Sciences at UT Austin, a private donor, and donations of reagents from New England Biolabs.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics committee/IRB of The University of Texas at Austin gave ethical approval for this work (IRB Protocol 2013-12-007).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript. LAMPLoop-mediated AMPlificationPTCPositive Template ControlNTCNegative Template ControlLODLimit of DetectionmolH2Omolecular biology grade nuclease free waterEM2Ember Temperature Control Smart Mug 2